Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Translational Pediatrics
|
February 3, 2016
Emerging technologies in paediatric leukaemia
Amanda Dixon-McIver
Methods in Molecular Biology (Clifton, N.J.)
|
September 10, 2010
MicroRNA detection in bone marrow cells by LNA-FISH
Silvana Debernardi, Amanda Dixon-McIver
Cancer Genetics
|
November 21, 2017
Detection of complex genomic signatures associated with risk in plasma cell disorders
Nadine K Berry, Amanda Dixon-McIver, Rodney J Scott, et al.
The New Zealand Medical Journal
|
June 21, 2022
Validation of a molecular assay to detect SARS-CoV-2 in saliva
Janet L Pitman, Arthur J Morris, Stephen Grice, et al.
Plos One
|
May 15, 2008
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia
Amanda Dixon-McIver, Phil East, Charles A Mein, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 11, 2016
NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRASQ61R or KRASQ61R Mutation in Colorectal Carcinoma
John Turchini, Juliana Andrici, Loretta Sioson, et al.
Genes, Chromosomes & Cancer
|
March 28, 2003
Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2
Jennifer Snaddon, Matthew L Smith, Michael Neat, et al.
Internal Medicine Journal
|
July 19, 2019
Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non-small-cell lung cancer in New Zealand
Mark J McKeage, Sandar Tin Tin, Prashannata Khwaounjoo, et al.
Journal of Medical Genetics
|
February 2, 2020
ATR-16 syndrome: mechanisms linking monosomy to phenotype
Christian Babbs, Jill Brown, Sharon W Horsley, et al.
Cancer Genetics
|
November 1, 2018
Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms
Rashmi Kanagal-Shamanna, Jennelle C Hodge, Tracy Tucker, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Translational Pediatrics
|
February 3, 2016
Emerging technologies in paediatric leukaemia
Amanda Dixon-McIver
Methods in Molecular Biology (Clifton, N.J.)
|
September 10, 2010
MicroRNA detection in bone marrow cells by LNA-FISH
Silvana Debernardi, Amanda Dixon-McIver
Cancer Genetics
|
November 21, 2017
Detection of complex genomic signatures associated with risk in plasma cell disorders
Nadine K Berry, Amanda Dixon-McIver, Rodney J Scott, et al.
The New Zealand Medical Journal
|
June 21, 2022
Validation of a molecular assay to detect SARS-CoV-2 in saliva
Janet L Pitman, Arthur J Morris, Stephen Grice, et al.
Plos One
|
May 15, 2008
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia
Amanda Dixon-McIver, Phil East, Charles A Mein, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
February 11, 2016
NRASQ61R Mutation-specific Immunohistochemistry is Highly Specific for Either NRASQ61R or KRASQ61R Mutation in Colorectal Carcinoma
John Turchini, Juliana Andrici, Loretta Sioson, et al.
Genes, Chromosomes & Cancer
|
March 28, 2003
Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2
Jennifer Snaddon, Matthew L Smith, Michael Neat, et al.
Internal Medicine Journal
|
July 19, 2019
Screening for anaplastic lymphoma kinase (ALK) gene rearrangements in non-small-cell lung cancer in New Zealand
Mark J McKeage, Sandar Tin Tin, Prashannata Khwaounjoo, et al.
Journal of Medical Genetics
|
February 2, 2020
ATR-16 syndrome: mechanisms linking monosomy to phenotype
Christian Babbs, Jill Brown, Sharon W Horsley, et al.
Cancer Genetics
|
November 1, 2018
Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms
Rashmi Kanagal-Shamanna, Jennelle C Hodge, Tracy Tucker, et al.
Page
of 2